Celldex Therapeutics, Inc. · NASDAQ:CLDX
Wellington Management Group LLP reported a 12.20% stake in Celldex Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 10, 2026
Wellington Management Group LLP reported a 12.20% stake in Celldex Therapeutics, Inc., 8,079,608 shares, as a passive investor on Dec 31, 2025. Filed Feb 10, 2026 (Schedule 13G/A).
- Stake
- 12.20%
- Shares
- 8,079,608
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Wellington Management Group LLP | 12.20% | 8,079,608 |
| Wellington Group Holdings LLP | 12.20% | 8,079,608 |
| Wellington Investment Advisors Holdings LLP | 12.20% | 8,079,608 |
| Wellington Management Company LLP | 11.80% | 8,079,608 |
Source
Related
- Celldex Therapeutics, Inc.
- Wellington Management Group LLP
- Celldex Therapeutics, Inc. shareholders
- Schedule 13G/A · Wellington Management Group LLP · Nov 7, 2025
- Schedule 13G/A · Wellington Management Group LLP · Aug 12, 2025
- Schedule 13G/A · Wellington Management Group LLP · May 12, 2025
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Kynam Capital Management, LP · Aug 14, 2026
- Schedule 13G/A · Bellevue Group AG · May 15, 2026
- Schedule 13G/A · Kynam Capital Management, LP · May 15, 2026